Provided by Tiger Trade Technology Pte. Ltd.

Psyence Biomedical Ltd

2.40
+0.05002.13%
Post-market: 2.400.00000.00%19:37 EDT
Volume:5.15K
Turnover:12.27K
Market Cap:2.45M
PE:-1.14
High:2.46
Open:2.40
Low:2.30
Close:2.35
52wk High:74.94
52wk Low:1.92
Shares:1.02M
Float Shares:970.74K
Volume Ratio:0.37
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1050
EPS(LYR):32.76
ROE:-74.29%
ROA:-34.44%
PB:0.21
PE(LYR):0.07

Loading ...

Psyence Biomed Announces Settlement of Shareholder Litigation

THOMSON REUTERS
·
Feb 11

Psyence Biomedical Ltd - Co to Pay $1.5 Mln to Kaos Capital Under Settlement

THOMSON REUTERS
·
Feb 11

Cigna's Reassurances About PBM Business Lift Stock -- WSJ

Dow Jones
·
Feb 06

CVS Health Faces New PBM Transparency Test With Earnings Engine In Focus

Simply Wall St.
·
Feb 05

Top Premarket Decliners

MT Newswires Live
·
Feb 03

NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:31 AM

Reuters
·
Feb 02

NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM

Reuters
·
Feb 01

Psyence Biomedical Ltd trading halted, news pending

TIPRANKS
·
Jan 31

Psyence Biomedical Announces 1-for-6.25 Reverse Stock Split Effective February 2

Reuters
·
Jan 29

Psyence Biomed Announces Effective Date for 1-for-6.25 Reverse Stock Split

THOMSON REUTERS
·
Jan 29

Press Release: MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

Dow Jones
·
Jan 27

Press Release: Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026

Dow Jones
·
Jan 23

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:35 AM

Reuters
·
Jan 20

Psyence BioMed Postpones Planned Reverse Stock Split

Reuters
·
Jan 20

Psyence Biomed Announces Postponement of Previously Announced Reverse Stock Split Effective Date

THOMSON REUTERS
·
Jan 20

Psyence Biomedical Ltd trading halted, news pending

TIPRANKS
·
Jan 17

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Reuters
·
Jan 17

Psyence Biomed Announces Effective Date for 1-for-6.25 Reverse Stock Split

THOMSON REUTERS
·
Jan 15

Psyence BioMed Enacts 1-for-6.25 Reverse Stock Split

Reuters
·
Jan 15

BRIEF-Psyence Biomed Approves 2026 Financial Strategy, Board Authorizes Share Buyback On Value Opportunity

Reuters
·
Jan 12